150 related articles for article (PubMed ID: 28551891)
1. [BISPHOSPHONATES AND OCULAR INFLAMMATION].
Rappoport D; Leiba H
Harefuah; 2017 Feb; 156(2):71-73. PubMed ID: 28551891
[TBL] [Abstract][Full Text] [Related]
2. Bilateral uveitis secondary to bisphosphonate therapy.
Tan YL; Sims J; Chee SP
Ophthalmologica; 2009; 223(3):215-6. PubMed ID: 19221448
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates Related Ocular Side Effects: A Case Series and Review of Literature.
Gendelman O; Tripto-Shkolnik L; Vered I; Lidar M
Ocul Immunol Inflamm; 2022; 30(7-8):1995-1999. PubMed ID: 34014797
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates: from grandparents to grandchildren.
Srivastava T; Alon US
Clin Pediatr (Phila); 1999 Dec; 38(12):687-702. PubMed ID: 10618761
[TBL] [Abstract][Full Text] [Related]
5. Paget's disease: ocular complications of disodium pamidronate treatment.
O'Donnell NP; Rao GP; Aguis-Fernandez A
Br J Clin Pract; 1995; 49(5):272-3. PubMed ID: 7492469
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates in the treatment of disorders of mineral metabolism.
Singer FR; Minoofar PN
Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
[TBL] [Abstract][Full Text] [Related]
7. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
French DD; Margo CE
Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
[TBL] [Abstract][Full Text] [Related]
9. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
11. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
12. Skeletal bone diseases impact the periodontium: a review of bisphosphonate therapy.
Palomo L; Liu J; Bissada NF
Expert Opin Pharmacother; 2007 Feb; 8(3):309-15. PubMed ID: 17266466
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
Gutta R; Louis PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
[TBL] [Abstract][Full Text] [Related]
15. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
16. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
17. Ocular side effects associated with bisphosphonates.
Fraunfelder FW
Drugs Today (Barc); 2003 Nov; 39(11):829-35. PubMed ID: 14702129
[TBL] [Abstract][Full Text] [Related]
18. Alternative indications for bisphosphonate therapy.
Landesberg R; Eisig S; Fennoy I; Siris E
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):27-34. PubMed ID: 19371812
[TBL] [Abstract][Full Text] [Related]
19. [Bisphosphonates: indications in bone diseases other than osteoporosis].
Abdelmoula LC; Ben M'barek R; Ben Hadj Yahia C; Tekaya R; Testouri N; Chaabouni L; Zouari R
Tunis Med; 2011 Jun; 89(6):511-6. PubMed ID: 21681711
[TBL] [Abstract][Full Text] [Related]
20. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
Chatterjee S; Agrawal D
J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
